
{"id":198,"date":"2017-12-01T09:23:32","date_gmt":"2017-12-01T14:23:32","guid":{"rendered":"http:\/\/pages.charlotte.edu\/elo\/?page_id=198"},"modified":"2019-05-24T14:01:29","modified_gmt":"2019-05-24T18:01:29","slug":"updates","status":"publish","type":"page","link":"https:\/\/pages.charlotte.edu\/elo\/updates\/","title":{"rendered":"Latest News"},"content":{"rendered":"<p><span style=\"color: #23282d;font-size: 2em;font-weight: 600\">Latest news on malaria and other infectious diseases will be posted here. Share with me if you know any as well!<\/span><\/p>\n<h1><strong>2019<\/strong><\/h1>\n<h3>May 22, 2019<\/h3>\n<h4>Algeria and Argentina certified malaria-free by WHO<\/h4>\n<p>Excerpt from article: &#8220;Algeria and Argentina have been officially recognized by WHO as malaria-free. The certification is granted when a country proves that it has interrupted indigenous transmission of the disease for at least 3 consecutive years.<\/p>\n<p>Contracted through the bite of an infected mosquito, malaria remains one of the world\u2019s leading killers, with an estimated 219 million cases and over 400 000 malaria-related deaths in 2017. Approximately 60% of fatalities are among children aged under 5 years.<\/p>\n<p>Algeria is the second country in the WHO African Region to be officially recognized as malaria-free, after Mauritius, which was certified in 1973. Argentina is the second country in the WHO Region of the Americas to be certified in 45 years, after Paraguay in June 2018.<\/p>\n<p>Algeria and Argentina reported their last cases of indigenous malaria in 2013 and 2010 respectively.<\/p>\n<p>Link: https:\/\/www.who.int\/news-room\/detail\/22-05-2019-algeria-and-argentina-certified-malaria-free-by-who&#8221;<\/p>\n<h3>April 30, 2019<\/h3>\n<h4 class=\"page-header\">Malaria vaccine pilot launched in Ghana<\/h4>\n<p>Excerpt from article: &#8221;<\/p>\n<p>WHO Ghana welcomed the Ministry of Health\u2019s launch of the world\u2019s first malaria vaccine in a landmark pilot programme. Top health officials, WHO representatives, community leaders, and mothers and children gathered on 30 April 2019 to officially begin the vaccine rollout. The country-led phased vaccine introduction is supported by WHO and national and global health partners.<\/p>\n<p>Ghana is one of three African countries in which the vaccine, known as RTS,S, will be made available to children up to 2 years of age.<\/p>\n<p>Malaria remains one of the world\u2019s leading killers, claiming the life of one child every two minutes; most of these deaths are in Africa. In Ghana, about 20 percent of all children have malaria parasites in their blood.<\/p>\n<p>\u201cThis is a day to celebrate,\u201d said WHO Representative for Ghana Dr Owen Kaluwa. \u201cThis breakthrough in malaria control caps a 30-year effort to develop a vaccine with proven results to help prevent malaria in young children. The malaria vaccine has the potential to save tens of thousands of children\u2019s lives.\u201d<\/p>\n<p>Dr Kaluwa congratulated the Ministry of Health of Ghana for its commitment to the RTS,S vaccine pilot and what it could mean to improve child health and malaria control.<\/p>\n<p>A roster of distinguished speakers participated in the event, including the Director-General of the Ghana Health Service Dr Anthony Nsiah-Asare. Deputy Minister of Health the Honorable Alexander K. K. Abban gave keynote remarks and then officially announced the vaccine pilot underway.<\/p>\n<p>Susana and Abigail, both age 6 months, were then vaccinated \u2013 the first children to receive the malaria vaccine in the Ghana pilot \u2013 in front of the attending audience of about 300 health workers, national immunization and malaria specialists and community supporters.&#8221;<\/p>\n<div id=\"attachment_550\" style=\"width: 310px\" class=\"wp-caption alignnone\"><a href=\"http:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2019\/05\/Ghana_malaria_vaccine_baby_crying.png\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-550\" class=\"wp-image-550 size-medium\" src=\"http:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2019\/05\/Ghana_malaria_vaccine_baby_crying-300x241.png\" alt=\"\" width=\"300\" height=\"241\" srcset=\"https:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2019\/05\/Ghana_malaria_vaccine_baby_crying-300x241.png 300w, https:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2019\/05\/Ghana_malaria_vaccine_baby_crying-768x616.png 768w, https:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2019\/05\/Ghana_malaria_vaccine_baby_crying.png 806w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><p id=\"caption-attachment-550\" class=\"wp-caption-text\">Susana and Abigail, both 6 months, are the first to receive the RTS,S vaccine in Ghana. Photography credit: WHO\/Fanjan Combrink<\/p><\/div>\n<h3>April 23, 2019<\/h3>\n<h4>World&#8217;s First Malaria Vaccine Launches In Sub-Saharan Africa<\/h4>\n<div class=\"video-container\"><iframe loading=\"lazy\" title=\"Working to beat malaria: the Malaria Vaccine Implementation Programme\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/1CJF7uC5npE?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/div>\n<p>&#8220;Today health officials are making history. They&#8217;re\u00a0<a href=\"https:\/\/www.who.int\/news-room\/detail\/23-04-2019-malaria-vaccine-pilot-launched-in-malawi\">rolling out<\/a>\u00a0the first approved vaccine aimed at stopping a human parasite. It&#8217;s for malaria \u2014 and the hopes are that one day the vaccine could save the lives of tens of thousands of children each year.<\/p>\n<p>&#8220;This [rollout] is a massive success of the research community,&#8221; says\u00a0<a href=\"https:\/\/www.who.int\/malaria\/news\/2014\/pedroalonso_bio\/en\/\">Dr. Pedro Alonso<\/a>, who directs the Global Malaria Programme at the World Health Organization.<\/p>\n<p>This vaccine \u2014 called\u00a0<a href=\"https:\/\/www.malariavaccine.org\/files\/MVI-GSK-FAQ-FINAL-web.pdf\">RTS,S<\/a>\u00a0\u2014 is one of the few immunizations designed and launched specifically to help young children in Africa, says\u00a0<a href=\"https:\/\/www.path.org\/leadership\/deborah-atherly\/\">Deborah Atherly<\/a>\u00a0at PATH, a nonprofit that helped develop the immunization.<\/p>\n<p>&#8220;It&#8217;s a pro-poor vaccine, if you will,&#8221; Atherly says. &#8220;I think that&#8217;s also a really important milestone in vaccine development and introduction.&#8221;<\/p>\n<p>Malaria is still a top killer of children worldwide, but children in Africa are most affected. Every two minutes a child or baby there dies of the disease. Some children can have up to six bouts of malaria in just one year, says Dr. Mary Hamel of WHO.<\/p>\n<p>The vaccine took more than 30 years \u2014 and more than $500 million \u2014 to develop. It was an international collaboration among WHO, PATH, the pharmaceutical company\u00a0<a href=\"https:\/\/www.gsk.com\/\">GlaxoSmithKline<\/a>\u00a0and a network of African countries. The Bill &amp; Melinda Gates Foundation \u2014 which is a sponsor of NPR and this blog \u2014 is also a funder of the vaccine.&#8221;<\/p>\n<p>Link:\u00a0https:\/\/www.npr.org\/sections\/goatsandsoda\/2019\/04\/23\/716378835\/worlds-first-malaria-vaccine-launches-in-sub-saharan-africa?utm_campaign=storyshare&amp;utm_source=facebook.com&amp;utm_medium=social<\/p>\n<h3>January 22, 2019<\/h3>\n<h4>Quinine&#8217;s Target<\/h4>\n<p>&#8220;Different classes of malaria drugs have been used for decades, even though the mechanisms of action have never been elucidated. To identify antimalarial drug targets, Dziekan\u00a0<em>et al.<\/em>\u00a0developed a protocol combining mass spectrometry and cellular thermal shift assay. The assay uses parasite lysate and intact infected red blood cells and was able to positively identify two known drug targets. They then investigated targets for quinine and mefloquine, revealing purine nucleoside phosphorylase as the top hit. Their results not only identify the likely target of these common drugs but also showcase an assay that could be widely used in antimalarial drug research.&#8221;<\/p>\n<p>Link:\u00a0http:\/\/blogs.sciencemag.org\/pipeline\/archives\/2019\/01\/22\/quinines-target<\/p>\n<p>http:\/\/stm.sciencemag.org\/content\/11\/473\/eaau3174<\/p>\n<h3>University of Florida, January 2, 2019<\/h3>\n<h2>New saliva-based test detects malaria before symptoms appear<\/h2>\n<div class=\"video-container\"><iframe loading=\"lazy\" title=\"12 18 18 MARL MAIN\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/LQpuIbTmgAE?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/div>\n<p>Link: http:\/\/news.ufl.edu\/articles\/2019\/01\/new-saliva-based-test-detects-malaria-before-symptoms-appear.php<\/p>\n<h2><strong>Want to learn more about Malaria? Take an online course from Harvard University<\/strong><\/h2>\n<h3>MalariaX:\u00a0<span class=\"text-size-heading\">Defeating Malaria from the Genes to the Globe<\/span><\/h3>\n<div class=\"video-container\"><iframe loading=\"lazy\" title=\"MalariaX: Defeating Malaria from the Genes to the Globe | HarvardX on edX\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/C0yrd-dfwp4?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/div>\n<p>Link: https:\/\/www.edx.org\/course\/defeating-malaria-genes-to-globe<\/p>\n<h1><strong>2018<\/strong><\/h1>\n<h3><a href=\"https:\/\/malariaworld.org\/blog\/7th-mim-pan-african-malaria-conference-dakar-april-15-20-2018\">MIM conference this year in Dakar, Senegal<\/a><\/h3>\n<p>There will be a symposium on Vivax malaria in Africa!<\/p>\n<p><a href=\"http:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2018\/03\/banniere-MIM.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-401\" src=\"http:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2018\/03\/banniere-MIM-300x90.jpg\" alt=\"\" width=\"470\" height=\"141\" srcset=\"https:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2018\/03\/banniere-MIM-300x90.jpg 300w, https:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2018\/03\/banniere-MIM.jpg 680w\" sizes=\"auto, (max-width: 470px) 100vw, 470px\" \/><\/a><\/p>\n<h3><a href=\"http:\/\/www.astmh.org\/annual-meeting\/schedule-at-a-glance\">Annual Conference &#8211; American Society of Tropical Medicine and Hygiene<\/a><\/h3>\n<p>This year in New Orleans!<\/p>\n<p><a href=\"http:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2018\/03\/astmh.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-402\" src=\"http:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2018\/03\/astmh-300x92.jpg\" alt=\"\" width=\"479\" height=\"147\" srcset=\"https:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2018\/03\/astmh-300x92.jpg 300w, https:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2018\/03\/astmh.jpg 650w\" sizes=\"auto, (max-width: 479px) 100vw, 479px\" \/><\/a><\/p>\n<h1><\/h1>\n<h1><\/h1>\n<h1><strong>2017<\/strong><\/h1>\n<p>The Guardian, Nov 29, 2017<\/p>\n<p><a href=\"https:\/\/www.theguardian.com\/global-development\/2017\/nov\/29\/malaria-is-back-on-the-rise-as-lack-of-funds-stalls-push-to-wipe-out-disease\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.theguardian.com\/global-development\/2017\/nov\/29\/malaria-is-back-on-the-rise-as-lack-of-funds-stalls-push-to-wipe-out-disease<\/a><\/p>\n<p><a href=\"http:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2017\/12\/3600.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-309\" src=\"http:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2017\/12\/3600-300x200.jpg\" alt=\"\" width=\"391\" height=\"260\" srcset=\"https:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2017\/12\/3600-300x200.jpg 300w, https:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2017\/12\/3600.jpg 620w\" sizes=\"auto, (max-width: 391px) 100vw, 391px\" \/><\/a><\/p>\n<p>World Malaria Report 2017 by WHO<\/p>\n<p><a href=\"http:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2017\/en\/\" target=\"_blank\" rel=\"noopener noreferrer\">http:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2017\/en\/<\/a><\/p>\n<p><a href=\"http:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2017\/12\/WMR-2017-cover_180px.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-307\" src=\"http:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2017\/12\/WMR-2017-cover_180px.jpg\" alt=\"\" width=\"180\" height=\"257\" \/><\/a><\/p>\n<p>CDC &#8211; Global Health<\/p>\n<p><a href=\"https:\/\/www.cdc.gov\/globalhealth\/inthenews.htm\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.cdc.gov\/globalhealth\/inthenews.htm<\/a><\/p>\n<p><a href=\"http:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2017\/12\/measles-vaccine-campaign-SierraLeone.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-305\" src=\"http:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2017\/12\/measles-vaccine-campaign-SierraLeone-300x166.jpg\" alt=\"\" width=\"381\" height=\"211\" srcset=\"https:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2017\/12\/measles-vaccine-campaign-SierraLeone-300x166.jpg 300w, https:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2017\/12\/measles-vaccine-campaign-SierraLeone-768x424.jpg 768w, https:\/\/pages.charlotte.edu\/elo\/wp-content\/uploads\/sites\/1210\/2017\/12\/measles-vaccine-campaign-SierraLeone.jpg 935w\" sizes=\"auto, (max-width: 381px) 100vw, 381px\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Latest news on malaria and other infectious diseases will be posted here. Share with me if you know any as well! 2019 May 22, 2019 Algeria and Argentina certified malaria-free by WHO Excerpt from article: &#8220;Algeria and Argentina have been officially recognized by WHO as malaria-free. The certification is granted when a country proves that [&hellip;]<\/p>\n","protected":false},"author":1132,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-198","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/pages.charlotte.edu\/elo\/wp-json\/wp\/v2\/pages\/198","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pages.charlotte.edu\/elo\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pages.charlotte.edu\/elo\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pages.charlotte.edu\/elo\/wp-json\/wp\/v2\/users\/1132"}],"replies":[{"embeddable":true,"href":"https:\/\/pages.charlotte.edu\/elo\/wp-json\/wp\/v2\/comments?post=198"}],"version-history":[{"count":27,"href":"https:\/\/pages.charlotte.edu\/elo\/wp-json\/wp\/v2\/pages\/198\/revisions"}],"predecessor-version":[{"id":554,"href":"https:\/\/pages.charlotte.edu\/elo\/wp-json\/wp\/v2\/pages\/198\/revisions\/554"}],"wp:attachment":[{"href":"https:\/\/pages.charlotte.edu\/elo\/wp-json\/wp\/v2\/media?parent=198"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}